Century Therapeutics Stock Forecast

Buy or Hold candidate since Jun 18, 2026 Gain 6.11%

The Century Therapeutics, Inc. stock price gained 1.67% on the last trading day (Thursday, 2nd Jul 2026), rising from $2.39 to $2.43. During the last trading day the stock fluctuated 5.94% from a day low at $2.36 to a day high of $2.50. The price has risen in 8 of the last 10 days and is up by 8% over the past 2 weeks. Volume fell on the last day by -1 million shares and in total, 839 thousand shares were bought and sold for approximately $2.04 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Century Therapeutics, Inc. stock with a 90% probability to be traded between $2.04 and $2.55 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

IPSC Signals & Forecast

The Century Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.37 and $2.28. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 30, 2026, and so far it has fallen -0.82%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Century Therapeutics, Inc. stock

Century Therapeutics, Inc. finds support from accumulated volume at $2.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.140 between high and low, or 5.94%. For the last week, the stock has had daily average volatility of 9.56%.

Our recommended stop-loss: $2.34 (-3.55%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (IPSC) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Century Therapeutics, Inc. to open at $2.43, and during the day (based on 14 day Average True Range), to move between $2.34 and $2.52, which gives a possible trading interval of +/-$0.181 (+/-7.73%) up or down from last closing price. If Century Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.73% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.45 (0.82%) than the support at $2.32 (4.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Century Therapeutics, Inc. stock A Buy?

Century Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.205 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $2.43 ( 0.137%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk